INDUSTRY OVERVIEW
The Structural Heart Devices is Growing at 11.90% and is expected to reach USD35.1Billion by 2033. Below mentioned are some of the dynamics shaping the Structural Heart Devices.Structural Heart Devices Market Size in (USD Billion) CAGR Growth Rate 11.90%
| Study Period | 2020-2033 |
| Market Size (2025): | USD14.5Billion |
| Market Size (2033): | USD35.1Billion |
| CAGR (2025 - 2033): | 11.90% |
| Fastest Growing Region | Asia-Pacific |
| Dominating Region | North America |
www.htfmarketinsights.com
Structural heart devices are medical implants or tools used to treat heart defects such as valve diseases or septal defects. Unlike traditional open-heart surgeries, modern devices are often delivered through catheters, reducing hospital stays and recovery time. The growing prevalence of heart disease among aging populations, coupled with advancements in 3D imaging and transcatheter techniques, is fueling demand. Major players are investing in next-gen and hybrid solutions to improve outcomes.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Regulatory Landscape
- Regulated under FDA PMA, CE MDR, and ISO 5840.
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Aging Population And Heart Disease Rise
- Minimally Invasive Procedure Demand
- Innovation In Cardiology
- Growing Awareness Of Valve Diseases
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- High Cost Of Devices
- Regulatory Complexity
- Surgical Expertise Shortage
- Post-procedure Complications
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Use of AI in device placement
- Development of transcatheter therapies
- Wearable monitoring integration
- Biodegradable implants
Market Opportunities:
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Growth In Emerging Markets
- Partnerships With Med-tech Startups
- Expansion Of Outpatient Cardiac Care
- Development Of Remote Monitoring Platforms
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- TAVR
- TMVR
- Annuloplasty Devices
- Occluders
Structural Heart Devices Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Aortic stenosis
- Mitral regurgitation
- ASD closure
- Heart failure
- Pediatric defects
Structural Heart Devices Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Asia-Pacific is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Asia-Pacific
Dominating Region
North America
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- Edwards Lifesciences (USA)
- Medtronic (Ireland)
- Abbott (USA)
- Boston Scientific (USA)
- LivaNova (UK)
- CryoLife (USA)
- JenaValve (Germany)
- MicroPort Scientific (China)
- Corvia Medical (USA)
- CardioMech (Norway)
- HighLife SAS (France)
- Xeltis (Netherlands)
- Peijia Medical (China)
- Lepu Medical (China)
Structural Heart Devices Market Segmentation by Players
www.htfmarketinsights.com
Regional Analysis
- Strong demand in North America and Western Europe; rising in India.
Market Entropy
- June 2025: Edwards Lifesciences announced a new-generation TAVR device for high-risk patients, enhancing valve durability and delivery precision.
Merger & Acquisition
- April 2025 – Edwards Lifesciences acquired a French startup working on non-invasive valve repair systems. Post-acquisition, they launched a next-gen transcatheter tricuspid repair device.
Regulatory Landscape
- Regulated under FDA PMA, CE MDR, and ISO 5840.
Patent Analysis
- Patents in deployable frame design, biocompatible coatings, and delivery systems.
Investment and Funding Scenario
- Large investments from MedTech venture arms and hospital groups.
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2025 |
|
Based Year Market Size (2023) |
USD14.5Billion |
|
Historical Period |
2020 to 2025 |
|
CAGR (2025 to 2033) |
11.90% |
|
Forecast Period |
2025 to 2033 |
|
Forecasted Period Market Size (2033) |
USD35.1Billion |
|
Scope of the Report |
Segmentation by Type TAVR,TMVR,Annuloplasty Devices,Occluders, Segmentation by Application Aortic stenosis,Mitral regurgitation,ASD closure,Heart failure,Pediatric defects, Sales Channel |
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
Edwards Lifesciences (USA),Medtronic (Ireland),Abbott (USA),Boston Scientific (USA),LivaNova (UK),CryoLife (USA),JenaValve (Germany),MicroPort Scientific (China),Corvia Medical (USA),CardioMech (Norway),HighLife SAS (France),Xeltis (Netherlands),Peijia Medical (China),Lepu Medical (China) |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Structural Heart Devices - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Structural Heart Devices Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Structural Heart Devices Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Structural Heart Devices Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Aging population and heart disease rise
- 3.1.2 Minimally invasive procedure demand
- 3.1.3 Innovation in cardiology
- 3.1.4 Growing awareness of valve diseases
-
3.2 Available Opportunities
- 3.2.1 Growth in emerging markets
- 3.2.2 Partnerships with med-tech startups
- 3.2.3 Expansion of outpatient cardiac care
- 3.2.4
-
3.3 Influencing Trends
- 3.3.1 Use of AI in device placement
- 3.3.2 Development of transcatheter therapies
- 3.3.3 Wearable monitoring integration
-
3.4 Challenges
- 3.4.1 High cost of devices
- 3.4.2 Regulatory complexity
- 3.4.3 Surgical expertise shortage
- 3.4.4 Post-procedure complications
- 3.4.5
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Structural Heart Devices Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Structural Heart Devices Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Structural Heart Devices : Competition Benchmarking & Performance Evaluation
- 5.1 Global Structural Heart Devices Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Structural Heart Devices Revenue 2025
- 5.3 Global Structural Heart Devices Sales Volume by Manufacturers (2025)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 Heat Map Analysis
- 5.6 Strategic Group Analysis
Chapter 6: Global Structural Heart Devices Market: Company Profiles
- 6.1 Edwards Lifesciences (USA)
- 6.1.1 Edwards Lifesciences (USA) Company Overview
- 6.1.2 Edwards Lifesciences (USA) Product/Service Portfolio & Specifications
- 6.1.3 Edwards Lifesciences (USA) Key Financial Metrics
- 6.1.4 Edwards Lifesciences (USA) SWOT Analysis
- 6.1.5 Edwards Lifesciences (USA) Development Activities
- 6.2 Medtronic (Ireland)
- 6.3 Abbott (USA)
- 6.4 Boston Scientific (USA)
- 6.5 LivaNova (UK)
- 6.6 CryoLife (USA)
- 6.7 JenaValve (Germany)
- 6.8 MicroPort Scientific (China)
- 6.9 Corvia Medical (USA)
- 6.10 CardioMech (Norway)
- 6.11 HighLife SAS (France)
- 6.12 Xeltis (Netherlands)
- 6.13 Peijia Medical (China)
- 6.14 Lepu Medical (China)
- 6.15 Venus Medtech (China)
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Structural Heart Devices by Type & Application (2020-2033)
-
7.1 Global Structural Heart Devices Market Revenue Analysis (USD Million) by Type (2020-2025)
- 7.1.1 TAVR
- 7.1.2 TMVR
- 7.1.3 Annuloplasty Devices
- 7.1.4 Occluders
- 7.1.5 Repair Clips
-
7.2 Global Structural Heart Devices Market Revenue Analysis (USD Million) by Application (2020-2025)
- 7.2.1 Aortic Stenosis
- 7.2.2 Mitral Regurgitation
- 7.2.3 ASD Closure
- 7.2.4 Heart Failure
- 7.2.5 Pediatric Defects
- 7.3 Global Structural Heart Devices Market Revenue Analysis (USD Million) by Type (2025-2033)
- 7.4 Global Structural Heart Devices Market Revenue Analysis (USD Million) by Application (2025-2033)
Chapter 8 : North America Structural Heart Devices Market Breakdown by Country, Type & Application
- 8.1 North America Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 8.2.1 TAVR
- 8.2.2 TMVR
- 8.2.3 Annuloplasty Devices
- 8.2.4 Occluders
- 8.2.5 Repair Clips
-
8.3 North America Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 8.3.1 Aortic Stenosis
- 8.3.2 Mitral Regurgitation
- 8.3.3 ASD Closure
- 8.3.4 Heart Failure
- 8.3.5 Pediatric Defects
- 8.4 North America Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 8.5 North America Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 8.6 North America Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Structural Heart Devices Market Breakdown by Country, Type & Application
- 9.1 LATAM Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 9.2.1 TAVR
- 9.2.2 TMVR
- 9.2.3 Annuloplasty Devices
- 9.2.4 Occluders
- 9.2.5 Repair Clips
-
9.3 LATAM Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 9.3.1 Aortic Stenosis
- 9.3.2 Mitral Regurgitation
- 9.3.3 ASD Closure
- 9.3.4 Heart Failure
- 9.3.5 Pediatric Defects
- 9.4 LATAM Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 9.5 LATAM Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 9.6 LATAM Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 10 : West Europe Structural Heart Devices Market Breakdown by Country, Type & Application
- 10.1 West Europe Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 10.2.1 TAVR
- 10.2.2 TMVR
- 10.2.3 Annuloplasty Devices
- 10.2.4 Occluders
- 10.2.5 Repair Clips
-
10.3 West Europe Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 10.3.1 Aortic Stenosis
- 10.3.2 Mitral Regurgitation
- 10.3.3 ASD Closure
- 10.3.4 Heart Failure
- 10.3.5 Pediatric Defects
- 10.4 West Europe Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 10.5 West Europe Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 10.6 West Europe Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 11 : Central & Eastern Europe Structural Heart Devices Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 11.2.1 TAVR
- 11.2.2 TMVR
- 11.2.3 Annuloplasty Devices
- 11.2.4 Occluders
- 11.2.5 Repair Clips
-
11.3 Central & Eastern Europe Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 11.3.1 Aortic Stenosis
- 11.3.2 Mitral Regurgitation
- 11.3.3 ASD Closure
- 11.3.4 Heart Failure
- 11.3.5 Pediatric Defects
- 11.4 Central & Eastern Europe Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 11.5 Central & Eastern Europe Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 11.6 Central & Eastern Europe Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 12 : Northern Europe Structural Heart Devices Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 12.2.1 TAVR
- 12.2.2 TMVR
- 12.2.3 Annuloplasty Devices
- 12.2.4 Occluders
- 12.2.5 Repair Clips
-
12.3 Northern Europe Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 12.3.1 Aortic Stenosis
- 12.3.2 Mitral Regurgitation
- 12.3.3 ASD Closure
- 12.3.4 Heart Failure
- 12.3.5 Pediatric Defects
- 12.4 Northern Europe Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 12.5 Northern Europe Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 12.6 Northern Europe Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 13 : Southern Europe Structural Heart Devices Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 13.2.1 TAVR
- 13.2.2 TMVR
- 13.2.3 Annuloplasty Devices
- 13.2.4 Occluders
- 13.2.5 Repair Clips
-
13.3 Southern Europe Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 13.3.1 Aortic Stenosis
- 13.3.2 Mitral Regurgitation
- 13.3.3 ASD Closure
- 13.3.4 Heart Failure
- 13.3.5 Pediatric Defects
- 13.4 Southern Europe Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 13.5 Southern Europe Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 13.6 Southern Europe Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 14 : East Asia Structural Heart Devices Market Breakdown by Country, Type & Application
- 14.1 East Asia Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 14.2.1 TAVR
- 14.2.2 TMVR
- 14.2.3 Annuloplasty Devices
- 14.2.4 Occluders
- 14.2.5 Repair Clips
-
14.3 East Asia Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 14.3.1 Aortic Stenosis
- 14.3.2 Mitral Regurgitation
- 14.3.3 ASD Closure
- 14.3.4 Heart Failure
- 14.3.5 Pediatric Defects
- 14.4 East Asia Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 14.5 East Asia Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 14.6 East Asia Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 15 : Southeast Asia Structural Heart Devices Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 15.2.1 TAVR
- 15.2.2 TMVR
- 15.2.3 Annuloplasty Devices
- 15.2.4 Occluders
- 15.2.5 Repair Clips
-
15.3 Southeast Asia Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 15.3.1 Aortic Stenosis
- 15.3.2 Mitral Regurgitation
- 15.3.3 ASD Closure
- 15.3.4 Heart Failure
- 15.3.5 Pediatric Defects
- 15.4 Southeast Asia Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 15.5 Southeast Asia Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 15.6 Southeast Asia Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 16 : South Asia Structural Heart Devices Market Breakdown by Country, Type & Application
- 16.1 South Asia Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 16.2.1 TAVR
- 16.2.2 TMVR
- 16.2.3 Annuloplasty Devices
- 16.2.4 Occluders
- 16.2.5 Repair Clips
-
16.3 South Asia Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 16.3.1 Aortic Stenosis
- 16.3.2 Mitral Regurgitation
- 16.3.3 ASD Closure
- 16.3.4 Heart Failure
- 16.3.5 Pediatric Defects
- 16.4 South Asia Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 16.5 South Asia Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 16.6 South Asia Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 17 : Central Asia Structural Heart Devices Market Breakdown by Country, Type & Application
- 17.1 Central Asia Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 17.2.1 TAVR
- 17.2.2 TMVR
- 17.2.3 Annuloplasty Devices
- 17.2.4 Occluders
- 17.2.5 Repair Clips
-
17.3 Central Asia Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 17.3.1 Aortic Stenosis
- 17.3.2 Mitral Regurgitation
- 17.3.3 ASD Closure
- 17.3.4 Heart Failure
- 17.3.5 Pediatric Defects
- 17.4 Central Asia Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 17.5 Central Asia Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 17.6 Central Asia Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 18 : Oceania Structural Heart Devices Market Breakdown by Country, Type & Application
- 18.1 Oceania Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 18.2.1 TAVR
- 18.2.2 TMVR
- 18.2.3 Annuloplasty Devices
- 18.2.4 Occluders
- 18.2.5 Repair Clips
-
18.3 Oceania Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 18.3.1 Aortic Stenosis
- 18.3.2 Mitral Regurgitation
- 18.3.3 ASD Closure
- 18.3.4 Heart Failure
- 18.3.5 Pediatric Defects
- 18.4 Oceania Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 18.5 Oceania Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 18.6 Oceania Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 19 : MEA Structural Heart Devices Market Breakdown by Country, Type & Application
- 19.1 MEA Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 19.2.1 TAVR
- 19.2.2 TMVR
- 19.2.3 Annuloplasty Devices
- 19.2.4 Occluders
- 19.2.5 Repair Clips
-
19.3 MEA Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 19.3.1 Aortic Stenosis
- 19.3.2 Mitral Regurgitation
- 19.3.3 ASD Closure
- 19.3.4 Heart Failure
- 19.3.5 Pediatric Defects
- 19.4 MEA Structural Heart Devices Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 19.5 MEA Structural Heart Devices Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 19.6 MEA Structural Heart Devices Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Structural Heart Devices market is expected to see value worth USD 14.5 Billion in 2025.
According to the report,the Structural Heart Devices Industry size is projected to reach USD 35.1 Billion, exhibiting a CAGR of 11.90% by 2033.
Use Of AI In Device Placement,Development Of Transcatheter Therapies,Wearable Monitoring Integration,Biodegradable Implants,Custom Patient-specific Devices are seen to make big Impact on Structural Heart Devices Market Growth.
- Aging Population And Heart Disease Rise
- Minimally Invasive Procedure Demand
- Innovation In Cardiology
- Growing Awareness Of Valve Diseases
- Expansion Of Healthcare Infrastructure
As Industry players prepare to scale up, Structural Heart Devices Market sees major concern such as High Cost Of Devices,Regulatory Complexity,Surgical Expertise Shortage,Post-procedure Complications,Long Development Cycles.
Some of the opportunities that Analyst at HTF MI have identified in Structural Heart Devices Market are:
- Growth In Emerging Markets
- Partnerships With Med-tech Startups
- Expansion Of Outpatient Cardiac Care
- Development Of Remote Monitoring Platforms
- Collaboration With Telehealth Services
New entrants, including competitors from unrelated industries along with players such as Edwards Lifesciences (USA),Medtronic (Ireland),Abbott (USA),Boston Scientific (USA),LivaNova (UK),CryoLife (USA),JenaValve (Germany),MicroPort Scientific (China),Corvia Medical (USA),CardioMech (Norway),HighLife SAS (France),Xeltis (Netherlands),Peijia Medical (China),Lepu Medical (China),Venus Medtech (China) Instituting a robust process in Global Structural Heart Devices Market.
Research paper of Global Structural Heart Devices Market shows that companies are making better progress than their supply chain peers –including suppliers, majorly in end-use applications such as Aortic stenosis,Mitral regurgitation,ASD closure,Heart failure,Pediatric defects.
The Global Structural Heart Devices Market Study is segmented by TAVR,TMVR,Annuloplasty Devices,Occluders,Repair Clips.
The Global Structural Heart Devices Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
The Structural Heart Devices Market is studied from 2020 - 2033.
Structural heart devices are medical implants or tools used to treat heart defects such as valve diseases or septal defects. Unlike traditional open-heart surgeries, modern devices are often delivered through catheters, reducing hospital stays and recovery time. The growing prevalence of heart disease among aging populations, coupled with advancements in 3D imaging and transcatheter techniques, is fueling demand. Major players are investing in next-gen and hybrid solutions to improve outcomes.
